Skip to main content
. Author manuscript; available in PMC: 2021 Aug 11.
Published before final editing as: J Psychosom Res. 2020 Feb 11;131:109963. doi: 10.1016/j.jpsychores.2020.109963

Table 3.

Characteristics of the study population according to number of mental health concerns at 12 months of follow up.

Number of mental health concerns at 12 months P-Value
0 1 2 3
n = 752 n = 133 n = 42 n = 30
Demographics
Age 68.2 ± 8.8 67.0 ± 10.3 63.9 ± 10.0 59.9 ± 8.0 < 0.001
Male Gender 486 (64.6%) 80 (60.2%) 23 (54.8%) 18 (60.0%) 0.16
Race: White/Caucasian 639 (85.0%) 103 (77.4%) 30 (71.4%) 20 (66.7%) < 0.001
Country 0.50
  (1) USA 448 (59.6%) 80 (60.2%) 29 (69.0%) 26 (86.7%)
  (2) Netherlands 262 (34.8%) 27 (20.3%) 7 (16.7%) 2 (6.7%)
  (3) Australia 42 (5.6%) 26 (19.5%) 6 (14.3%) 2 (6.7%)
Smoke status < 0.001
  (1) Never 79 (10.5%) 14 (10.5%) 3 (7.1%) 1 (3.3%)
  (2) Former 425 (56.6%) 62 (46.6%) 18 (42.9%) 11 (36.7%)
  (3) Current 247 (32.9%) 57 (42.9%) 21 (50.0%) 18 (60.0%)
Insured 748 (99.5%) 132 (99.2%) 42 (100%) 29 (96.7%) 0.23
Work for pay 72 (38.1%) 15 (48.4%) 3 (33.3%) 3 (60.0%) 0.34
Finances at end of month < 0.001
  (1) Some money leftover 441 (60.4%) 60 (46.9%) 13 (31.7%) 6 (20.0%)
  (2) Just enough to make ends meet 236 (32.3%) 51 (39.8%) 22 (53.7%) 12 (40.0%)
  (3) Not enough to make ends meet 53 (7.3%) 17 (13.3%) 6 (14.6%) 12 (40.0%)
PAD Characteristics
Complaint 0.74
  (1) New-onset 404 (53.7%) 68 (51.1%) 22 (52.4%) 16 (53.3%)
  (2) Exacerbation 348 (46.3%) 65 (48.9%) 20 (47.6%) 14 (46.7%)
Duration of pain 0.51
  (1) < 1 Month 19 (3.0%) 1 (0.9%) 0 (0.0%) 1 (3.7%)
  (2) 1–6 Months 192 (30.0%) 37 (32.2%) 9 (24.3%) 7 (25.9%)
  (3) 7–12 Months 110 (17.2%) 18 (15.7%) 10 (27.0%) 5 (18.5%)
  (4) > 12 Months 318 (49.8%) 59 (51.3%) 18 (48.6%) 14 (51.9%)
Symptomatic leg 0.05
  (1) Right leg 193 (25.7%) 33 (24.8%) 5 (11.9%) 8 (26.7%)
  (2) Left leg 196 (26.1%) 30 (22.6%) 13 (31.0%) 2 (6.7%)
  (3) Both legs 363 (48.3%) 70 (52.6%) 24 (57.1%) 20 (66.7%)
Claudication 748 (99.5%) 133 (100.0%) 42 (100.0%) 30 (100.0%) 0.36
Location of highest claudication 0.11
  (1) Buttock 124 (16.6%) 20 (15.0%) 13 (31.0%) 6 (20.0%)
  (2) Hip 71 (9.5%) 15 (11.3%) 1 (2.4%) 0 (0.0%)
  (3) Thigh 99 (13.2%) 28 (21.1%) 7 (16.7%) 4 (13.3%)
  (4) Calf 391 (52.3%) 62 (46.6%) 19 (45.2%) 20 (66.7%)
  (5) Foot 10 (1.3%) 3 (2.3%) 2 (4.8%) 0 (0.0%)
  (6) Other 53 (7.1%) 5 (3.8%) 0 (0.0%) 0 (0.0%)
Rutherford category 0.039
  (1) Mild claudication 181 (24.4%) 27 (20.3%) 6 (14.3%) 5 (16.7%)
  (2) Moderate claudication 365 (49.3%) 66 (49.6%) 20 (47.6%) 16 (53.3%)
  (3) Severe claudication 195 (26.3%) 40 (30.1%) 16 (38.1%) 9 (30.0%)
Lesion Site 0.67
  (1) Proximal 210 (28.1%) 37 (28.0%) 14 (33.3%) 3 (10.0%)
  (2) Distal 215 (28.8%) 41 (31.1%) 14 (33.3%) 12 (40.0%)
  (3) Both 322 (43.1%) 54 (40.9%) 14 (33.3%) 15 (50.0%)
ABI 0.67 ± 0.19 0.64 ± 0.20 0.67 ± 0.18 0.73 ± 0.17 0.07
Co-morbidities
Hypertension 603 (80.2%) 110 (82.7%) 34 (81.0%) 25 (83.3%) 0.53
Dyslipidemia 589 (78.3%) 103 (77.4%) 36 (85.7%) 26 (86.7%) 0.21
Diabetes 236 (31.4%) 46 (34.6%) 18 (42.9%) 12 (40.0%) 0.08
TIA/CVA 74 (9.8%) 24 (18.0%) 8 (19.0%) 4 (13.3%) 0.015
History of CAD 327 (43.5%) 59 (44.4%) 26 (61.9%) 17 (56.7%) 0.024
Congestive heart failure 66 (8.8%) 18 (13.5%) 7 (16.7%) 1 (3.3%) 0.39
Chronic kidney disease 75 (10.0%) 18 (13.5%) 6 (14.3%) 2 (6.7%) 0.59
Chronic lung disease 117 (15.6%) 23 (17.3%) 5 (11.9%) 10 (33.3%) 0.10
Sleep apnea 56 (7.4%) 12 (9.0%) 5 (11.9%) 3 (10.0%) 0.26
Osteoarthritis (hip or knee) 63 (8.4%) 15 (11.3%) 5 (11.9%) 1 (3.3%) 0.86
Chronic back pain 105 (14.0%) 21 (15.8%) 9 (21.4%) 3 (10.0%) 0.63
History of depression 22 (2.9%) 7 (5.3%) 3 (7.1%) 2 (6.7%) 0.044
Health status
EQ5D: Score your health today (BL) 68.2 ± 18.4 65.2 ± 18.7 58.1 ± 15.2 48.8 ± 22.5 < 0.001
EQ5D: Score your health today (12 M) 73.2 ± 16.4 68.5 ± 74.0 55.3 ± 18.7 53.5 ± 18.2 < 0.001
ESSI Social Support Score (BL) 22.7 ± 3.9 21.0 ± 5.2 18.4 ± 6.8 19.2 ± 6.2 < 0.001
PAQ: Quality of life (BL) 55.2 ± 24.5 42.5 ± 25.0 28.8 ± 24.0 25.8 ± 24.1 < 0.001
PAQ: Quality of life (12 M) 77.5 ± 23.8 58.4 ± 28.9 41.8 ± 28.8 34.5 ± 28.1 < 0.001
PAQ: Summary (BL) 53.3 ± 20.5 41.5 ± 21.2 30.3 ± 18.8 28.8 ± 18.8 < 0.001
PAQ: Summary (12 M) 75.3 ± 22.3 58.9 ± 26.4 42.3 ± 25.7 33.3 ± 25.7 < 0.001
PAQ: Physical limitation (BL) 42.3 ± 26.6 29.9 ± 22.9 21.7 ± 20.1 19.0 ± 17.0 < 0.001
PAQ: Physical limitation (12 M) 74.0 ± 27.9 56.1 ± 33.3 39.8 ± 31.9 34.7 ± 33.1 < 0.001
PAQ: Symptoms (BL) 46.8 ± 21.7 39.6 ± 24.3 28.9 ± 20.2 29.1 ± 24.7 < 0.001
PAQ: Symptoms (12 M) 66.4 ± 28.5 52.6 ± 30.4 38.0 ± 25.7 31.2 ± 26.6 < 0.001
PAQ: Social limitation (BL) 68.4 ± 28.1 52.5 ± 29.3 40.2 ± 29.7 37.5 ± 27.3 < 0.001
PAQ: Social limitation (12 M) 87.6 ± 20.1 73.0 ± 27.3 55.1 ± 32.5 40.2 ± 28.8 < 0.001

ABI = ankle brachial index, TIA = transient ischemic attack, CVA = cerebral vascular accident, CAD = coronary artery disease, ESSI = Enriched Social Support Index, PAQ = Peripheral Artery Questionnaire, BL = baseline, 12 M = 12 months.